Mixed response to thalidomide therapy in adults: Two cases of multisystem langerhans' cell histiocytosis [7]

Acta Dermato-Venereologica

Volumn 82, Issue 5, 2002, Pages 384-386

  Kolde, Gerhard ^a   Schulze, Peter ^a   Sterry, Wolfram ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

THALIDOMIDE;

ADULT; CASE REPORT; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HISTIOCYTOSIS X; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY DIAGNOSIS; LETTER; MALE; MONOTHERAPY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SEDATION; SIDE EFFECT; SKIN MANIFESTATION; TREATMENT FAILURE;

ADMINISTRATION, ORAL; ADULT; ANUS DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SKIN DISEASES; THALIDOMIDE; TREATMENT OUTCOME;

EID: 0036401696     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/000155502320624186     Document Type: Letter

References (15)

1. Chu AC. Histiocytoses. In: Champion RH, Burton JL, Burns DA, Breathnach SM, eds. Textbook of dermatology. 6th Ed. Vol. 3. Oxford: Blackwell Scientific Publications, 1998: 2311-2336.
2. Caputo R. Langerhans' cell histiocytosis. In: Freedberg IM, Eisen AM, Wolff K, Austen KF, Goldsmith LA, Katz SI, et al., eds. Fitzpatrick's Dermatology in General Medicine. 5th Ed. Vol. II. New York: McGraw-Hill, 1999: 1882-1892.
3. Gadner H, Grois N, Arico M, Broadbent V, Ceci A, Jakobson A, et al. A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. J Pediatr 2001; 138: 728-734.
4. Gnassia AM, Gnassia RT, Bonvalet D, Puissant A, Goudal H. Histiocytose X avec "granulome eosinophile vulvaire". Effet spectaculaire de la thalidomide. Ann Dermatol Venereol 1987; 114: 1387-1389.
5. Bensaid P, Machet L, Vaillant L, Machet MC, Scotto B, Lorette G. Histiocytose langerhansienne de l'adulte: Localisation parotidienne regressive après traitement par thalidomide. Ann Dermatol Venereol 1992; 119: 281-283.
6. Thomas L, Ducros B, Secchi T, Balme B, Moulin G. Successful treatment of adult's Langerhans' cell histiocytosis with thalidomide. Report of two cases and literature review. Arch Dermatol 1993; 129: 1261-1264.
7. Gerlach B, Stein A, Fischer R, Wozel G, Dittert DD, Richter G. Langerhanszell-Histiozytose im Alter. Hautarzt 1998; 49: 23-30.
8. Lair G, Marie I, Cailleux N, Blot E, Boullie MC, Courville P, et al. Histiocytose langerhansienne de l'adulte: Localisations cutaneomuqueuses regressives après traitement par thalidomide. Rev Med Interne 1998; 19: 196-198.
9. Baumgartner I, von Hochstetter A, Baumert B, Luetolf U, Follath F. Langerhans' cell histiocytosis in adults. Med Pediatr Oncol 1997; 28: 9-14.
10. Giona F, Caruso R, Testi AM, Moleti ML, Malagnino F, Martelli M, et al. Langerhans' cell histiocytosis in adults - A clinical and therapeutic analysis of 11 patients from a single institution. Cancer 1997; 80: 1786-1791.
11. Allen BR. Thalidomide. Br J Dermatol 2001; 144: 227-228.
12. Meierhofer C, Dunzendorfer S, Wiedermann CJ. Theoretical basis for the activity of thalidomide. BioDrugs 2001; 15: 681-703.
13. Egeler RM, Favara BE, van Meurs M, Laman JD, Claassen E. Differential in situ cytokine profiles of Langerhans-like cells and T cells in Langerhans' cell histiocytosis: Abundant expression of cytokines relevant to disease and treatment. Blood 1999; 94: 4195-4201.
14. Tazi A, Moreau J, Bergeron A, Dominique S, Hance AJ, Soler P. Evidence that Langerhans' cells in adult pulmonary Langerhans' cell histiocytosis are mature dendritic cells: Importance of the cytokine microenvironment. J Immunol 1999; 163: 3511-3515.
15. Henter JI, Karlén J, Calming U, Bernstrand C, Andersson U, Fadeel B. Successful treatment of Langerhans' cell histiocytosis with etanercept. N Engl J Med 2001; 345: 1577-1578.